Medicine recalls
|
| |
| Batch recall of “Fluphenazin-Neuraxpharm D Solution for Injection 25mg/ml” |
| |
The Department of Health (DH) today (1 Dec) endorsed licensed wholesaler, Hind Wing Company Limited (Hind Wing) to recall a batch (batch number 202052) of Fluphenazin-Neuraxpharm D Solution for Injection 25mg/ml (HK- 64620) due to potential quality issue.
The DH received notification from Hind Wing that the overseas manufacturer has recalled several batches of the product because, based on tests done on the filter cartridges used in the production of the product, it was found that there was potential leach of additives from the filter cartridges. As a precautionary measure, Hind Wing is voluntarily recalling the affected batch. DH investigation is continuing.
The above product is a prescription medicine and is indicated for schizophrenia. According to Hind Wing, only one affected batch of the product has been imported into Hong Kong and supplied to the Hospital Authority, private doctor and pharmacy.
Hind Wing has set up a hotline (2541 5731) to answer related enquiries. The DH will closely monitor the recall
So far, the DH has not received any adverse reaction reports in connection with the above batch of product.
End/ 1 Dec 2022
|
| |
|
